Western Digital's Q4 Earnings Ahead: Key Trends Investors Should Watch — Negative

WDC   Zacks Investment Research — July 28, 2025

WDC eyes sequential revenue growth in fiscal Q4 2025, fueled by cloud demand, AI-driven storage and a $2B buyback in place amid cost pressures.

image for news Western Digital's Q4 Earnings Ahead: Key Trends Investors Should Watch

S&P Global to Report Q2 Earnings: Here's What You Should Know — Positive

SPGI   Zacks Investment Research — July 28, 2025

SPGI's second-quarter 2025 earnings are expected to have risen on strong product demand, market positioning and recurring revenue gains.

image for news S&P Global to Report Q2 Earnings: Here's What You Should Know

Home BancShares (HOMB) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Positive

HOMB   Zacks Investment Research — July 28, 2025

Home BancShares (HOMB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

image for news Home BancShares (HOMB) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

How Much Upside is Left in Kennedy-Wilson (KW)? Wall Street Analysts Think 30.26% — Positive

KW   Zacks Investment Research — July 28, 2025

The consensus price target hints at a 30.3% upside potential for Kennedy-Wilson (KW). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news How Much Upside is Left in Kennedy-Wilson (KW)? Wall Street Analysts Think 30.26%

Should You Buy Alphabet Inc. (GOOG) After Golden Cross? — Positive

GOOG  GOOGL   Zacks Investment Research — July 28, 2025

After reaching an important support level, Alphabet Inc. (GOOG) could be a good stock pick from a technical perspective. GOOG recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

image for news Should You Buy Alphabet Inc. (GOOG) After Golden Cross?

The average of price targets set by Wall Street analysts indicates a potential upside of 90.6% in Revolution Medicines (RVMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade

The mean of analysts' price targets for Geo Group (GEO) points to a 60.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts See a 60.15% Upside in Geo Group (GEO): Can the Stock Really Move This High?

Enovix Corporation (ENVX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive

ENVX   Zacks Investment Research — July 28, 2025

Enovix Corporation (ENVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

image for news Enovix Corporation (ENVX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEM

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

image for news Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating MediaAlpha Inc. for potential violations of securities laws

Fubo has accelerated the expected timeline for closing its sale to Disney, now anticipating the transaction will close in the fourth quarter of this year or the first three months of 2026. It requires regulatory approval with a review ongoing at the Department of Justice.

image for news Fubo Sees Disney, Hulu + Live TV Deal Closing Earlier Than Anticipated

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

Can Optum Support UnitedHealth's Profit Amid Industry Headwinds? — Negative

UNH   Zacks Investment Research — July 28, 2025

UNH leans on Optum's diversified growth and value-based care to counter insurance sector margin pressure in Q2.

image for news Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?

Bank of Marin (BMRC) Q2 Earnings Miss Estimates — Negative

BMRC   Zacks Investment Research — July 28, 2025

Bank of Marin (BMRC) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.06 per share a year ago.

image for news Bank of Marin (BMRC) Q2 Earnings Miss Estimates

Here's Why BOK Financial (BOKF) is a Strong Momentum Stock — Positive

BOKF   Zacks Investment Research — July 28, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why BOK Financial (BOKF) is a Strong Momentum Stock

Here's Why Exelixis (EXEL) is a Strong Momentum Stock — Positive

EXEL   Zacks Investment Research — July 28, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Exelixis (EXEL) is a Strong Momentum Stock

Here's Why Barrick Mining (B) is a Strong Momentum Stock — Positive

B   Zacks Investment Research — July 28, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Barrick Mining (B) is a Strong Momentum Stock

Here's Why Dentsply International (XRAY) is a Strong Momentum Stock — Positive

XRAY   Zacks Investment Research — July 28, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Dentsply International (XRAY) is a Strong Momentum Stock

Charter Communications, Inc. CHTR reported a second-quarter EPS miss on Friday.

image for news These Analysts Cut Their Forecasts On Charter Communications Following Q2 Earnings